Ki67: comment l'évaluer? = How to evaluate Ki67HERLIN, Paulette.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S49-S51, HS1Conference Paper

Ki67 et tumeurs neuroendocrines = Ki67 and neuroendocrine tumorsCOUVELARD, Anne.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S55-S56, HS1Conference Paper

Increased Ki-67 proliferative index and absence of P16^INK4in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesionKUO, K.-T; CHANG, H.-C; HSIAO, C.-H et al.British journal of ophthalmology. 2006, Vol 90, Num 7, pp 894-899, issn 0007-1161, 6 p.Article

Nuclear β-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant formWONG, S. C. C; CHAN, A. T. C; CHAN, J. K. C et al.Journal of clinical pathology. 2006, Vol 59, Num 4, pp 387-392, issn 0021-9746, 6 p.Article

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence scoreSAHEBJAM, S; ALOYZ, R; PILAVDZIC, D et al.British journal of cancer. 2011, Vol 105, Num 9, pp 1342-1345, issn 0007-0920, 4 p.Article

Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?MIRZA, S; JEANNON, J. P; SOAMES, J et al.Acta oto-laryngologica. 2006, Vol 126, Num 4, pp 418-421, issn 0001-6489, 4 p.Article

Up-regulation of peroxidase proliferator- activated receptor_γ in cholesteatomaSOON JAE HWANG; HEE JOON KANG; SONG, Jae-Jun et al.The Laryngoscope. 2006, Vol 116, Num 1, pp 58-61, issn 0023-852X, 4 p.Article

Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanomaHAZAN, Carole; MELZER, Kate; PANAGEAS, Katherine S et al.Cancer. 2003, Vol 95, Num 3, pp 634-640, issn 0008-543XArticle

Steroid receptors and proliferation in the human breastCLARKE, Robert B.Steroids. 2003, Vol 68, Num 10-13, pp 789-794, issn 0039-128X, 6 p.Conference Paper

Stromal CD10 expression is correlated with invasiveness and proliferation of extramammary Paget diseaseXIE, L. N; UCHI, H; HAYASHIDA, S et al.British journal of dermatology (1951). 2008, Vol 158, Num 6, pp 1389-1391, issn 0007-0963, 3 p.Article

High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomasHOOS, Axel; STOJADINOVIC, Alexander; MASTORIDES, Stephen et al.Cancer. 2001, Vol 92, Num 4, pp 869-874, issn 0008-543XArticle

Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinomaGAYED, Bishoy A; YOUSSEF, Ramy F; BAGRODIA, Aditya et al.BJU international (Papier). 2014, Vol 113, Num 4, pp 668-673, issn 1464-4096, 6 p.Article

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH ProteinANDREASSON, Hakan; WANDERS, Alkwin; SUN, Xiao-Feng et al.Anticancer research. 2012, Vol 32, Num 4, pp 1443-1448, issn 0250-7005, 6 p.Article

Comparative validation of the SP6 antibody to Ki67 in breast cancerZABAGLO, Lila; SALTER, Janine; ANDERSON, Helen et al.Journal of clinical pathology. 2010, Vol 63, Num 9, pp 800-804, issn 0021-9746, 5 p.Article

Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphomaBROYDE, Adi; BOYCOV, Olga; STRENOV, Yulia et al.American journal of hematology. 2009, Vol 84, Num 6, pp 338-343, issn 0361-8609, 6 p.Article

The Expression of MT1 Melatonin Receptor and Ki-67 Antigen in Melanoma MalignumDANIELCZYK, Karolina; DZIEGIEL, Piotr.Anticancer research. 2009, Vol 29, Num 10, pp 3887-3895, issn 0250-7005, 9 p.Article

Bcl-2 and Bax in congenital naeviSTEFANAKI, C; ANTONIOU, C; STEFANAKI, K et al.British journal of dermatology (1951). 2006, Vol 154, Num 6, pp 1175-1179, issn 0007-0963, 5 p.Article

Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancyMEHROTRA, Pallavi; GONZALEZ, Michael A; JOHNSON, Sarah J et al.The Laryngoscope. 2006, Vol 116, Num 8, pp 1434-1438, issn 0023-852X, 5 p.Article

Prognostic value of Ki-67 expression in localized cutaneous malignant melanomaHENRIQUE, Rui; AZEVEDO, Rosa; BENTO, Maria José et al.Journal of the American Academy of Dermatology. 2000, Vol 43, Num 6, pp 991-1000, issn 0190-9622Article

Decreased PITX1 gene expression in human cutaneous malignant melanoma and its clinicopathological significanceOSAKI, Mitsuhiko; CHINEN, Hikari; YOSHIDA, Yuichi et al.EJD. European journal of dermatology. 2013, Vol 23, Num 3, pp 344-349, issn 1167-1122, 6 p.Article

Validity of the proliferation markers Ki67, TOP2A, and RacGAPl in molecular subgroups of breast cancerMILDE-LANGOSCH, Karin; KARN, Thomas; MÜLLER, Volkmar et al.Breast cancer research and treatment. 2013, Vol 137, Num 1, pp 57-67, issn 0167-6806, 11 p.Article

Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomasMÜSSIG, Karsten; WEHRMANN, Tobias; DITTMANN, Helmut et al.Clinical endocrinology (Oxford. Print). 2012, Vol 77, Num 1, pp 139-145, issn 0300-0664, 7 p.Article

Optic nerve gliomas: role of Ki-67 staining of tumour and margins in predicting long-term outcomeYEUNG, Sonia N; WHITE, Valerie A; NIMMO, Michael et al.British journal of ophthalmology. 2011, Vol 95, Num 8, pp 1077-1081, issn 0007-1161, 5 p.Article

Apoptosis and Cell Proliferation Correlated with Tumor Grade in Patients with Ampullary CarcinomaKALOGERAKI, Alexandra; TZARDI, Maria; PAPADAKIS, Michael et al.Acta cytologica. 2010, Vol 54, Num 1, pp 39-42, issn 0001-5547, 4 p.Article

Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areasOHTA, Kouji; OGAWA, Ikuko; ONO, Shigehiro et al.Oncology reports. 2010, Vol 24, Num 1, pp 9-14, issn 1021-335X, 6 p.Article